Navigation Links
Cell skeleton may hold key to overcoming drug resistance in cancer
Date:10/4/2007

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Childrens Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cells cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs, said Associate Professor Kavallaris.

This is the first scientific evidence for the broader implications of abnormal expression of this protein.

We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs, said Associate Professor Kavallaris.


'/>"/>

Contact: Pearly Harumal
pharumal@ccia.org.au
029-962-5663
Research Australia
Source:Eurekalert

Related medicine news :

1. Skeleton May Sustain Damage Due To Use Of Anti-Depressants
2. UF scientists Throw light on the origin of vertebrate skeleton
3. Culling followed by checking: Government to audit the documents, to ascertain no skeletons in the closet!
4. Discovery Of Human Skeletons Could Unfold Facts About By-Gone Ages
5. Overcoming actively may help in breast cancer
6. Overcoming Chronic Fatigue
7. Anorexia - Overcoming Hunger Pangs Isn’t Just About Will Powe
8. Anonymity Helps In Overcoming Inhibitions During Online Counseling
9. Mans Best Friend Could Be a Useful Companion in Overcoming Depression
10. New antibiotic already developing resistance
11. Adopting Easier Methods To Screen Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company ... recently met with big-name retail buyers at the January ECRM Trade Show in Hilton ... uses the utmost safety standards in all of its creations to help create a ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company that ... product to the United States as part of its presence to expand its market ... aims to reduce the productions of nasty toxins as a result of drinking alcohol, ...
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global business ... recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, strongly ... to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice are ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni ... line-up of events for its annual meeting “Coming Home 2017,” an activity-packed weekend ... Home 2017” will be held on Friday January 27 through Sunday, January 29, ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , January 23, 2017 Stock-Callers.com ... Pharmaceuticals Inc. (NASDAQ: CPRX ), Sophiris Bio Inc. ... MNTA ), and Agile Therapeutics Inc. (NASDAQ: ... which turned somewhat lower in late trade on Friday, January ... dropping about 0.3%, while shares of health care companies in ...
(Date:1/23/2017)... , 23. Januar 2017  ResMed (NYSE: ... und 3B Medical ( Winter Haven, Florida ... Vereinbarung über die Beilegung aller globalen Rechtsstreitigkeiten zwischen den ... Verkauf ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren ... an 3B leisten, um das in Florida ...
(Date:1/22/2017)... ABU DHABI , Saudi Arabia , January 22, 2017 ... the US and UAE ... Future , at the World Economic Forum   ... be driven by big data and powered by artificial intelligence and this trend ... that discussed the ,Hospital of the Future, at the concluding day of the ...
Breaking Medicine Technology: